Sociedad Americana de Hirudoterapia

Comparative genomics suggests extensive antithrombotic gene expansion in Haemadipsa yanyuanensis

Comparative genomics published in BMC Genomics (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyGenómica y proteómicaFarmacología salivalLin Y et al. · BMC genomics, 2025

Abstract

Haemadipsa yanyuanensis Liu & Song, 1977, is a terrestrial blood-feeding leech whose antithrombotic repertoire remains insufficiently characterized. We present its first chromosome-level genome assembly (165.32 Mb across nine chromosomes; BUSCO: 97.6%) using Nanopore long reads, Hi-C scaffolding, and RNA-seq data. We identified 193 putative antithrombotic genes in 15 putative families, representing a 2.2- to 2.7-fold increase in gene number but reduced family diversity compared with aquatic medicinal leeches, including Hirudo nipponia Whitman, 1886, Hirudinaria manillensis Lesson, 1842, and Hirudo medicinalis Linnaeus, 1758. Notably, the putative bdellin, LDTI, and LCI gene families exhibited marked lineage-specific expansions, ranging from 8.7- to 25-fold relative to those of aquatic leeches. In addition, the putative progranulin gene displayed a distinctive structural organization characterized by 122 cysteine residues and nine tandem repeats. Transcriptomic profiling revealed elevated expression of four expanded putative families, suggesting potential roles in terrestrial blood-feeding adaptation. This chromosome-scale genome provides a valuable resource for investigating anticoagulation mechanisms and may inform the development of next-generation antithrombotic therapeutics.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleComparative Study
Indexed MeSH termsAnimalsLeechesGenomicsPhylogenyFibrinolytic AgentsGenomeTranscriptomeGene Expression Profiling

Resumen

Comparative genomic analysis of the Yanyuan land leech Haemadipsa yanyuanensis showing dramatic expansion of antithrombotic gene families including hirudin-like factors and Kazal-type inhibitors.

Por qué esto importa para la hirudoterapia

This study presents the first chromosome-level genome assembly (165.32 Mb across nine chromosomes; BUSCO 97.6%) of the terrestrial blood-feeding leech Haemadipsa yanyuanensis, identifying 193 putative antithrombotic genes across 15 families—a 2.2- to 2.7-fold increase in gene number but reduced family diversity compared with aquatic medicinal leeches (Hirudo nipponia, Hirudinaria manillensis, Hirudo medicinalis). Bdellin, LDTI, and LCI gene families showed marked lineage-specific expansions (8.7- to 25-fold), with transcriptomic profiling confirming elevated expression of four expanded families, suggesting roles in terrestrial blood-feeding adaptation. This is highly relevant to ASH's domain as it provides a genomic resource for understanding antithrombotic gene diversity and leech salivary repertoire evolution. Caveat: the findings are putative gene identifications based on comparative genomics and transcriptomics with no functional protein validation or bioactivity data presented.

Citación

Comparative genomics suggests extensive antithrombotic gene expansion in Haemadipsa yanyuanensis.

Lin Y et al. · BMC genomics, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.